share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Belldegrun Arie

SEC announcement ·  Jun 15 04:32
Summary by Futu AI
On June 12, 2024, Arie Belldegrun, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a significant transaction involving the company's Class A Common Stock. Belldegrun acquired 105,263 shares through the exercise or conversion of derivative securities, as per the latest SEC filing. Following this transaction, Belldegrun directly holds a total of 194,925 shares of Ginkgo Bioworks. Additionally, an indirect ownership through Bellco Legacy LLC accounts for 500,000 shares. The transaction reflects a notable change in Belldegrun's stake in the company, potentially signaling confidence in Ginkgo Bioworks' future prospects.
On June 12, 2024, Arie Belldegrun, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a significant transaction involving the company's Class A Common Stock. Belldegrun acquired 105,263 shares through the exercise or conversion of derivative securities, as per the latest SEC filing. Following this transaction, Belldegrun directly holds a total of 194,925 shares of Ginkgo Bioworks. Additionally, an indirect ownership through Bellco Legacy LLC accounts for 500,000 shares. The transaction reflects a notable change in Belldegrun's stake in the company, potentially signaling confidence in Ginkgo Bioworks' future prospects.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.